Exelgyn is a French pharmaceutical company specialized in women’s healthcare. Exelgyn was founded by the innovators in the termination of pregnancy field. The company is a pioneer in development and commercialization of the first selective progesterone receptor modulator (SPRM) in gynecology. 

Exelgyn is partner in the area of women's healthcare with high quality products and services designed for healthcare professionals and their patients.

Currently, Exelgyn’s products are registered and marketed in more than 30 countries where abortion is legal and where there is a medical infrastructure.



Novembre 2011

Press release HAS recommendations for MToP use.


Septembre 2011

AFSSAPS press release about MTP kit warning.


June 2013

Exelgyn launch their misoprostol indicated in medical termination of pregnancy up to 49 days of amenorrhea.

June 2014

25th anniversary of women’s access to medical abortion with Mifegyne.